Affiliation:
1. Shahid Sadoughi University of Medical Sciences, Yazd, Iran
2. International Campus, Shahid Sadoughi University of Medical Sciences, Yazd, Iran
3. Department of Surgery, Shahid Sadoughi Hospital, Shahid Sadoughi University of Medical Sciences, Yazd, Iran
Abstract
<b> Introduction:</b> Given the high prevalence of breast cancer, developing quick and accessible diagnostics solutions is critical. The BIRADS classification is a reliable method for assessing and estimating the risk of malignancy in breast lesions. </br></br> <b>Aim:</b> The aim of this study was to compare the results of core needle biopsy of breast lesions and sonographic findings based on the BIRADS category in Yazd. </br></br> <b>Materials and methods:</b> This retrospective analytical study was done on all core needle biopsy specimens referred to Mortaz hospital, Yazd, Iran from 2010 to 2019. Demographic data such as age, laterality of the lesion, BIRADS category, and pathology reports were extracted from patients' hospital folders. Data were analyzed by SPSS version 21. P < 0.05 was considered statistically significant. </br></br> <b>Results:</b> In total, 514 cases with a mean age of 43.9 ± 9.4 years were studied. Among them, 104 cases (20.2%) were malignant and 410 cases (79.8%) were benign. The most common benign and malignant lesions were fibroadenoma (24.9%), and infiltrative ductal carcinoma (83.7%) respectively. The most common BIRADS was class 4A (54.9%). Patients with benign lesions were mostly in the 3rd and 4th decade of life, while malignant lesions were more in the 4th and 5th decades, and this difference was statistically significant (P = 0.001). The correlation between ultrasound diagnoses (BIRADS) and pathology findings was statistically significant (P < 0.001). </br></br> <b>Conclusion</b>: Based on the results, there is a significant correlation between ultrasound outcomes according to BIRADS and pathology results, and the radiology-pathology accordance, owing to its high accuracy, can be very helpful in correctly diagnosing, monitoring, and managing the lesion
Reference29 articles.
1. Maqbool M., Bekele F., Fekadu G.: Treatment Strategies Against Triple-Negative Bre-ast Cancer: An Updated Review. Breast Cancer (Dove Med Press)., 2022; 14: 15–24.
2. Kaur S., Najm M.Z., Khan M.A. et al.: Drug-Resistant Breast Cancer: Dwelling the Hippo Pathway to Manage the Treatment. Breast Cancer (Dove Med Press)., 2021; 13: 691–700.
3. Rahimzadeh S., Burczynska B., Ahmadvand A. et al.: Geographical and socio-economic inequalities in female breast cancer incidence and mortality in Iran: A Bayesian spatial analysis of registry data. PLOS ONE., 2021: 16(3): e0248723.
4. Yavari P., Mosavizadeh M., Sadrol-Hefazi B., Mehrabi Y.: Reproductive charac-teristics and the risk of breast cancer – a case-control study in Iran. Asian Pac J Cancer Prev, 2005; 6(3): 370–375.
5. Britt K.L., Cuzick J., Phillips K.A.: Key steps for effective breast cancer prevention. Nat Rev Cancer., 2020; 20(8): 417–436.